RS2 Healthcare Partners completes first platform investment in medtech manufacturer KMM

RS2 Healthcare Partners’ inaugural platform investment in medtech manufacturer KMM signals growing private equity appetite in the middle-market healthcare manufacturing space. For credit professionals, this deal highlights the potential for leveraged financing opportunities tied to specialized medtech platforms, which often benefit from stable demand and innovation-driven growth. Monitoring how RS2 structures and finances this initial investment will provide insights into underwriting standards and risk appetite amid evolving healthcare sector dynamics.